What is ArriVent BioPharma, Inc.'s change in lease liabilities?

ArriVent BioPharma, Inc. (AVBP) reported change in lease liabilities of $47K in Q1 2026.

How has ArriVent BioPharma, Inc.'s change in lease liabilities changed year-over-year?

ArriVent BioPharma, Inc.'s change in lease liabilities increased by 1275.0% year-over-year, from -$4K to $47K.

What does change in lease liabilities mean?

Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.

ArriVent BioPharma, Inc. AVBP Change in Lease Liabilities

Change in Lease Liabilities at other companies

ImmunomeIMNM

-$161K-160%

Bicara TherapeuticsBCAX

-$270K-83.7%

BridgeBio PharmaBBIO

-$1.85M-26.0%

Revolution Medicines, Inc.RVMD

-$2.07M-38.1%

Roivant SciencesROIV

-$275K-14.1%

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.57B+62.1%

Enterprise value$1.51B+65.4%

Returns & leverage

See full

Return on equity-55.2%+8.0pp

Debt / equity0×0.0×

Current ratio14×-0.4×

Where this comes from

Reported directly by ArriVent BioPharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s change in lease liabilities?: ArriVent BioPharma, Inc. (AVBP) reported change in lease liabilities of $47K in Q1 2026.
How has ArriVent BioPharma, Inc.'s change in lease liabilities changed year-over-year?: ArriVent BioPharma, Inc.'s change in lease liabilities increased by 1275.0% year-over-year, from -$4K to $47K.
What does change in lease liabilities mean?: Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.